Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
421 to 440 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pruritogenic Mediators and New Antipruritic Drugs in Atopic Dermatitis. | J Clin Med | 2023 | 36983094 | PubTator, text mining | PubMed |
| In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis. | Int J Mol Sci | 2023 | 36982902 | PubTator, text mining | PubMed |
| Current and Future Therapeutical Options in Alport Syndrome. | Int J Mol Sci | 2023 | 36982595 | PubTator, text mining | PubMed |
| The Effect of Aldosterone on Cardiorenal and Metabolic Systems. | Int J Mol Sci | 2023 | 36982445 | PubTator, text mining | PubMed |
| Systemic Lupus Erythematosus and Pulmonary Hypertension. | Int J Mol Sci | 2023 | 36982160 | PubTator, text mining | PubMed |
| Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. | Cancers (Basel) | 2023 | 36980517 | PubTator, text mining | PubMed |
| Novel Oxidative Stress Biomarkers with Risk Prognosis Values in Heart Failure. | Biomedicines | 2023 | 36979896 | PubTator, text mining | PubMed |
| Perchlozone Resistance in Clinical Isolates of Mycobacterium tuberculosis. | Antibiotics (Basel) | 2023 | 36978456 | PubTator, text mining | PubMed |
| Identification and validation of tumor-infiltrating lymphocyte-related prognosis signature for predicting prognosis and immunotherapeutic response in bladder cancer. | BMC Bioinformatics | 2023 | 36973645 | PubTator, text mining | PubMed |
| Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer. | Front Oncol | 2023 | 36969037 | PubTator, text mining | PubMed |
| Sex differences in the intergenerational link between maternal and neonatal whole blood DNA methylation: a genome-wide analysis in 2 birth cohorts. | Clin Epigenetics | 2023 | 36966332 | PubTator, text mining | PubMed |
| Loss of biased signaling at a G protein-coupled receptor in overexpressed systems. | PLoS One | 2023 | 36961836 | PubTator, text mining | PubMed |
| A One Health approach revealed the long-term role of Mycobacterium caprae as the hidden cause of human tuberculosis in a region of Spain, 2003 to 2022. | Euro Surveill | 2023 | 36951787 | PubTator, text mining | PubMed |
| Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial. | Kidney360 | 2023 | 36951387 | PubTator, text mining | PubMed |
| Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial. | Eur Heart J Open | 2023 | 36950450 | PubTator, text mining | PubMed |
| Evidence that RXFP4 is located in enterochromaffin cells and can regulate production and release of serotonin. | Biosci Rep | 2023 | 36947541 | PubTator, text mining | PubMed |
| Pathogenesis of pulmonary hypertension caused by left heart disease. | Front Cardiovasc Med | 2023 | 36937903 | PubTator, text mining | PubMed |
| Assessing the epithelial-to-mesenchymal plasticity in a small cell lung carcinoma (SCLC) and lung fibroblasts co-culture model. | Front Mol Biosci | 2023 | 36936987 | PubTator, text mining | PubMed |
| Molecular cloning, characterization and 3D modelling of spotted snakehead fbn1 C-terminal region encoding asprosin and expression analysis of fbn1. | Sci Rep | 2023 | 36934166 | PubTator, text mining | PubMed |
| Blockade of endothelin-1 receptor B regulates molecules of the major histocompatibility complex in sickle cell disease. | Front Immunol | 2023 | 36926339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=22